HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The neuroprotective mechanism of puerarin in the treatment of acute spinal ischemia-reperfusion injury is linked to cyclin-dependent kinase 5.

Abstract
Puerarin is shown to exert a variety of pharmacological effects including neuroprotective properties. However, mechanisms of the action are not fully understood. This study was designed to explore the mechanism of puerarin in treatment of acute spinal ischemia-reperfusion injury in rats. Acute spinal ischemia-reperfusion injury was conducted by aortic occlusion in twenty-eight male Sprague-Dawley rats, weighting 230-250 g. The animals were randomly divided into four groups. In the animals with puerarin treatment, 50 mg/kg of puerarin was injected intraperitoneally after reperfusion, and followed by the same dose of injection every 24h for 2 days. In the animals with roscovitine pre-treatment, 30 mg/kg roscovitine was intravenously administrated 60 min before spinal ischemia started. After spinal ischemia for 60 min followed by 48 h of reperfusion, the motor function, spinal infarction volume, apoptosis indices and the activities of Cdk5 and p25 were examined. Acute spinal ischemia-reperfusion resulted in an injury of the spines associated with motor deficit, elevation of Cdk5 and p25 activities, and increase in the spinal apoptosis number and spinal infarction volume. Puerarin improved motor function associated with the decreased apoptosis number, spinal infarction volume, and Cdk5 and p25 activities. The present study indicated that reduction of spinal injury was associated with inhibition of Cdk5 and p25, and that inhibition of Cdk5 and p25 was one of the neuroprotective mechanisms in the puerarin treatment of acute ischemia/reperfusion-induced spinal injury in rats.
AuthorsFeng Tian, Li-Hui Xu, Bin Wang, Li-Jie Tian, Xiang-Lu Ji
JournalNeuroscience letters (Neurosci Lett) Vol. 584 Pg. 50-5 (Jan 01 2015) ISSN: 1872-7972 [Electronic] Ireland
PMID25301568 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Cdk5r1 protein, rat
  • Isoflavones
  • Neuroprotective Agents
  • Purines
  • Roscovitine
  • Phosphotransferases
  • Cyclin-Dependent Kinase 5
  • Cdk5 protein, rat
  • puerarin
Topics
  • Acute Disease
  • Animals
  • Apoptosis
  • Cyclin-Dependent Kinase 5 (metabolism)
  • Enzyme Activation
  • Infarction (pathology, prevention & control)
  • Isoflavones (therapeutic use)
  • Male
  • Neuroprotective Agents (therapeutic use)
  • Phosphotransferases (metabolism)
  • Purines (therapeutic use)
  • Rats, Sprague-Dawley
  • Reperfusion Injury (metabolism, pathology, physiopathology, prevention & control)
  • Roscovitine
  • Spinal Cord (drug effects, metabolism, pathology)
  • Spinal Cord Ischemia (metabolism, pathology, physiopathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: